Product overview
Vaccine type
Measles, Mumps and Rubella
Commercial Name
Priorix
Manofacturer
GlaxoSmithKline Biologicals SA
URL
Responsible NRA
Federal Agency for Medicines and Health Products
Country
Belgium
Prequalification
Prequalification Status
Current
Product description
Pharmaceutical Form
Lyophilised active component to be reconstituted with excipient diluent before use
Presentation
Vial
Number of Doses
2
Diluent
Water for Injection
Route of Administration
Intramuscular or Subcutaneous
Shelf Life
24 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 7
Secondary Packaging
a) Carton of 100 vials/200 doses (active)[Dimensions 17.8 x 14.7 x 3.7 cm]; b) Carton of 100 ampoules/200 doses (diluent) [Dimensions 19 x 18 x 7.5 cm]
Tertiary Packaging
a) Box of 24 cartons of 100 vials (active) (2400 vials/4800 doses)[Dimensions 34 x 25 x 43 cm]; b) Box of 8 cartons of 100 ampoules/1600 doses (diluent) [Dimensions 32 x 20 x 39 cm]
Multidose Vial Policy
Not Applicable.
Vaccine Preservative
none
Cold Chain Volume
a) 4.8 (vial); b)12.8 (ampoule) cm3/dose (in secondary packaging)